Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.

Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review.

PMID:
20008762
3.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
4.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;(8):CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
5.
6.

Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.

Zou Z, Yuan HB, Yang B, Xu F, Chen XY, Liu GJ, Shi XY.

Cochrane Database Syst Rev. 2016 Jan 27;(1):CD009210. doi: 10.1002/14651858.CD009210.pub2. Review.

PMID:
26816003
7.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
9.

Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis.

Caldeira D, David C, Sampaio C.

Am J Cardiovasc Drugs. 2012 Aug 1;12(4):263-77. doi: 10.2165/11599990-000000000-00000. Review.

PMID:
22587776
11.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
12.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
13.

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.

Crowley MJ, Powers BJ, Myers ER, McBroom AJ, Sanders GD.

Am Heart J. 2012 May;163(5):777-782.e8. doi: 10.1016/j.ahj.2012.02.016. Review.

PMID:
22607854
14.

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.

PMID:
19178130
15.

First-line drugs for hypertension.

Wright JM, Musini VM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001841. doi: 10.1002/14651858.CD001841.pub2. Review.

PMID:
19588327
16.

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3. Review.

PMID:
18454336
17.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
18.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines.

Gales BJ, Bailey EK, Reed AN, Gales MA.

Ann Pharmacother. 2010 Feb;44(2):360-6. doi: 10.1345/aph.1M312. Epub 2010 Jan 19. Review.

PMID:
20086184
19.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
20.

Antihypertensive agents for preventing diabetic kidney disease.

Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD004136. doi: 10.1002/14651858.CD004136.pub3. Review.

PMID:
23235603
Items per page

Supplemental Content

Write to the Help Desk